Cytori-The company

Cytori-The company (16)

 

This section -Cytori-The Company- describes many- and the most important aspects of the corporation Cytori Therapeutics. From its not so brilliant history and past years as a listed Company (>16 years now as we speak- early 2016, thereof 5 listed in Germany and 11 on Nasdaq), its management responsible for its development, its board which guided that management during those days and "represented shareholders", its mission and location and its partners- past, present and future and many other topics relevant to the Company, primarily its technology which separates it from Competition.  The basic technology as well as all applications will be described on fat-cell.com, another web presence of yours truly.

Monday, 09 January 2012 16:03

Cytori´s history- the years 2000-05

Written by
Article- History untill 2005.   Cytori became Cytori on July 11 2005 when the name change from MacroPore Biosurgery became official. Before that date, MacroPore obviously had some history too. That history started in 1997 when the company was founded by Chris Calhoun, Stefan Lemperle and Ralph Holmes. Holmes was a surgeon who left relatively soon thereafter to become CEO…
Last modified on Monday, 22 February 2016 02:07
Thursday, 12 January 2012 06:58

Reflections on Cytori- the years 2006-11

Written by
MacroPore was from an investors viewpoint- kind of "the dark side" of Cytori- not only because of the failed Medtronic partnership on bio-resorbable implants, but also because of excessive option-plans and failed guidances on revenues etc. The preceeding article "History" was a more objective article and facts driven- what follows is surely also "facts driven", but has definitely a more subjective colour,…
Last modified on Monday, 22 February 2016 02:09
Sunday, 29 January 2012 13:58

Cytori-its Managers-past and present

Written by
  The management Team Of Cytori. The team is led by one of its Co-founders - Christopher J. Calhoun Chief Executive Officer   Christopher J. Calhoun is a co-founder of Cytori Therapeutics and has served as the Company's Chief Executive Officer, Vice-Chairman and Director of the Board since 1997. He previously served as President from 1996 through 1998. Mr. Calhoun…
Last modified on Monday, 22 February 2016 02:10
Monday, 30 January 2012 16:22

Cytori- its Board Members-past and present

Written by
First- some historical development- Untill 2007 Cytori´s Board of Directors was more of an "good ol boys" club, although by SEC rules considered " pre-dominantly independent". The father-in-law of CEO Calhoun and Chairman of the Board, Marshall Cox "retired" in that year, meaning that the stock awards for BOD members could finally also be reduced to a "normal" level as happened…
Last modified on Monday, 22 February 2016 02:12
Wednesday, 29 February 2012 11:45

Cytori- its Partners-past and present-Olympus

Written by
Partner Olympus, as a Company, has major issues to resolve after the accounting cover-up scandal emerged. Dont want to comment that here, but you can read all about Woodford, Kikukawa and tobashi in the Wikipedia article- Link here According to Cytori management this scandal doesnt affect the relationship between Cytori and Olympus at all, which could be partially true, but new…
Last modified on Monday, 22 February 2016 02:13
Friday, 02 March 2012 19:13

Cytori- its Partners-past and present-Roche

Written by
Second partner I would like to present here is Hoffmann La Roche- short -Roche. In the same conference call early 2009 when Calhoun talked about his partners, he described the proprietary enzyme supplier as a "unnamed major US pharma partner, which we dont want to disclose for competitive reasons"- just to make things easy.(LOL) Roche is a top notch biotech, which is illustrated…
Last modified on Monday, 22 February 2016 02:17
Monday, 09 April 2012 18:13

Cytori- its Partners-past and present-Astellas

Written by
Actually Astellas is of course a little more than just a candidate, since on December 7, 2010 they took an equity participation in Cytori, with the first right to negotiate a deal on liver regeneration. Cytori explained this in a note as follows: Such a partnership would likely revolve around what we refer to as our Version 2.0 Celution® and…
Last modified on Monday, 22 February 2016 02:15
Sunday, 01 January 2012 16:57

Introduction to Cytori-The Company

Written by
Cytori´s Company slogan is: "Restoring Lives" - thereto its logo displays the slogan, which has been a few years longer around: "Where infinite possibilities meet" Both logo and slogan are really to my liking and I feel will be proven to become reality someday on a large- i.e. global scale. In  this section of the CYTX-Investor.com page all aspects of Cytori as a Nasdaq listed…

Media

Last modified on Saturday, 13 August 2016 09:51
Wednesday, 01 February 2012 10:50

Cytori- The Basic science of ADRCs

Written by
The basic science of Cytori- Properties of ADRC´s versus other cell sources This comes straight from the Cytori homepage: Science & Technology Cytori Therapeutics’ goal is to provide access to clinical grade Adipose-Derived Stem and Regenerative Cells (ADRCs). ADRCs, sometimes referred to as stromal vascular fraction cells, are a heterogeneous or mixed population of cells found in adipose tissue. This…
Last modified on Monday, 22 February 2016 05:08
Monday, 30 January 2012 18:17

Cytori- The Company- its Location

Written by
To start the first round of articles on Cytori- The Company with, just an quick overview of the location from which the world of regenerative medicine will be conquered and what these folks who are employed by Cytori- about 120 in total as we speak- call their daily home away from home.  
Last modified on Monday, 22 February 2016 02:19
Friday, 03 February 2012 15:48

Mechanisms of Therapeutic Action of ADRCs

Written by
In the Wall Street press one always reads, when the theme "stem cells" comes up, what the difference in adult- and embryonic cell differentiation potential is and what these magic things all can do, or what they cant do. Words like pluripotency, multipotency and sometimes even the word progenitor cell come up and are the buzz words, in providing an…
Last modified on Monday, 22 February 2016 05:06
Tuesday, 16 February 2016 16:56

Cytori- The Company

Written by
This section -Cytori-The Company- describes many- and most likely- the most important aspects of the corporate entity Cytori Therapeutics. From its not so brilliant history and years as a listed Company (>16 years now as we speak- early 2016, thereof 5 listed in Germany and 11 on Nasdaq), to its management responsible for its development, its board which guided that…
Last modified on Saturday, 11 June 2016 08:09
Saturday, 04 February 2012 16:34

The versatility of the Celution Extraction Device

Written by
There seem to be several misconceptions or maybe just different opinions about the ability for Cytori to protect the IP, which went into the designing- and engineering of the Celution range of products. Thereto different opinions about the technical superiority of the same system. I do not think the following write-up will eliminate differences of opinion, but provides sufficient additional…
Last modified on Monday, 22 February 2016 05:05
Sunday, 21 February 2016 14:52

Half a Can of Coke

Written by
Half a can of coke of fat tissue extracted from the subcuteneous part of the belly, is the standard introduction by all presenters of Cytori managers at Investor conferences over the past eight years, when they start describing what amount of fat is needed from a patient before that fat is processed by Celution to extract a therapeutic dose of…

Media

Last modified on Monday, 22 February 2016 05:02
Thursday, 02 February 2012 11:50

Cytori´s Intellectual Property Position

Written by
Build-up of Cytori´s Intellectual Property rights Especially with an emerging- and most likely disruptive technology, the protection of one´s IP is of prime importance. Obviously there are several ways to protect the business- secrecy- and privacy- for instance are also part of that, which is one of the reasons why I am doing this Investor HP- there is more to…
Last modified on Monday, 22 February 2016 05:07
Wednesday, 08 February 2012 18:00

Cytori´s Platform Applications

Written by
  Cytori´s immensely large technology platform The versatility of ADRC´s in general provides a gigantic opportunity for Cytori as a first mover in this space, to collect the low hanging fruit and establish themselves before others do so, whilst being protected by an impressive IP portfolio in the mean time. As a general rule of thumb, what has crystalized out…
Last modified on Wednesday, 24 February 2016 09:51

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites